Sterilization Lamination Adhesive With Fast Cure and Cohesion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing solvent-based two-component polyurethane adhesives used in lamination processes for flexible packaging face issues such as the formation of harmful primary aromatic amines, long crosslinking times, and inadequate cohesion during and after sterilization treatments, which affect industrial efficiency and safety.

Innovation Solution

A solvent-based two-component polyurethane adhesive composition comprising specific —OH and —NCO components, including amorphous prepolymers and aliphatic diisocyanates, which reduce the risk of primary aromatic amine formation and provide rapid crosslinking and enhanced cohesion, suitable for high-speed lamination processes and sterilization resistance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If conventional solvent-based two-component polyurethane adhesives are used in lamination processes, then initial tack and adhesion are achieved, but harmful primary aromatic amines are formed during storage and sterilization

Engineering Contradiction:
Improveformation of primary aromatic aminesVSAvoidadhesive performance
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent changes the chemical parameters of the adhesive system by replacing aromatic diisocyanates with aliphatic diisocyanates (such as HDI, IPDI, or PDI) and using specific polyol combinations. This parameter change eliminates the formation of harmful primary aromatic amines while maintaining adhesive performance through optimized molecular structure and crosslinking density.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the potential harm of amine formation into a benefit by designing a system where the isocyanate groups react with hydroxyl groups to form stable polyurethane linkages that do not degrade into harmful substances. The crosslinking reaction itself becomes the protective mechanism against harmful byproduct formation.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Loss of time

If conventional adhesives are used, then lamination bonding is achieved, but crosslinking time is excessively long (exceeding 2 days)

Engineering Contradiction:
Improvecrosslinking timeVSAvoidcohesion
Core Design Contradiction:
Loss of timeVSStrength

Solution Approach 1:

The patent applies preliminary action by incorporating latent catalysts or pre-activating the adhesive components in a controlled manner before application. The adhesive is formulated with precatalysts that remain dormant during storage but become active upon application, initiating rapid crosslinking without compromising shelf stability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces dynamic control of the crosslinking process through temperature-dependent catalyst activation or moisture-sensitive reaction mechanisms. The crosslinking rate dynamically adjusts based on environmental conditions, allowing fast initial set for productivity while ensuring complete curing for strength.

Inventive Principle:
Principle #15Dynamics

3Productivity

If high-speed lamination processes are implemented, then productivity increases, but adhesive cohesion during sterilization becomes inadequate

Engineering Contradiction:
Improveline speedVSAvoidcohesion during sterilization
Core Design Contradiction:
ProductivityVSStrength

Solution Approach 1:

The patent segments the curing process into distinct phases: initial rapid tack formation for high-speed lamination, intermediate crosslinking during storage, and final complete curing during or after sterilization. Each phase is optimized for its specific function, allowing productivity and sterilization resistance to coexist.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent provides beforehand cushioning by formulating the adhesive with excess isocyanate groups or latent crosslinking agents that ensure complete curing even under accelerated sterilization conditions. This over-engineering of the crosslinking capacity guarantees sufficient cohesion despite reduced residence time during sterilization.

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

4Object-affected harmful factors

If aliphatic diisocyanates are used to eliminate aromatic amine formation, then safety improves, but crosslinking reactivity decreases

Engineering Contradiction:
Improvearomatic amine formationVSAvoidcrosslinking speed
Core Design Contradiction:
Object-affected harmful factorsVSProductivity

Solution Approach 1:

The patent uses catalysts as intermediaries to mediate between the low reactivity of aliphatic diisocyanates and the requirement for fast crosslinking. Organometallic catalysts or organic bases accelerate the reaction kinetics without affecting the safety profile, enabling fast curing with safe chemistries.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a composite adhesive system combining aliphatic diisocyanates with specific polyols, extenders, and catalysts. This composite formulation compensates for the lower inherent reactivity of aliphatic diisocyanates through synergistic interactions among components, achieving both safety and productivity.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The adhesive composition achieves rapid crosslinking within two days, ensures initial tack for multi-layer film production, and maintains cohesion through sterilization, eliminating health risks and enabling efficient industrial production.

Implementation Method 1

a solvent-based two-component polyurethane adhesive composition comprising an —OH component and an —NCO component

Methodology Applied
Scientific EffectCrosslinking reaction: Chemical Bonding

Implementation Method 2

maintains cohesion through sterilization

Methodology Applied
Scientific EffectThermal resistance: Heat Treatment

Data Source

PatentUS12545823B2Lamination adhesive for sterilisation
Publication Date: 2026.02.10 BOSTIK SA(FR)
  • US12545823B2 patent drawing
  • US12545823B2 patent drawing
  • US12545823B2 patent drawing

AI summary

A solvent-based two-component polyurethane-type adhesive composition comprises an —OH component and an —NCO component. The —OH component comprises an amorphous prepolymer including two —OH end groups, with a number-average molar mass Mn of 8000 to 12,000 g and is chosen from: a) a copolyester (A1) obtained by a polycondensation reaction of at least one aliphatic diol (i) with at least one aromatic diacid (ii) and at least one aliphatic diacid (iii); and b) a polyurethane (A2) obtained by a polyaddition reaction between an aliphatic diisocyanate compound and an amorphous copolyester diol with a number-average molecular weight Mn ranging from 4000 to 11 500 g/mol. The —NCO component comprises a compound (B1) including three —NCO end groups, obtained by the reaction of meta-xylylene diisocyanate (m-XDI) with a triol, said compound (B1) being alone or as a mixture with a compound (B2) derived from an aliphatic diisocyanate.